A blood sugar biomarker identifies patients with atherosclerosis and a risk of cardiovascular events
The routine use of the glycosylated hemoglobin test to track blood sugar levels in the general population can identify individuals with more advanced atherosclerotic disease. Currently used in the diagnosis and management ...
Jun 1, 2021
0
535